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Abstract
Astaxanthin	 is	a	marine	carotenoid	that	has	a	number	of	potential	health	benefits,	 including	a	very	strong	
antioxidant	potential.	Present	in	the	flesh	of	salmonids	and	shellfish,	its	natural	sources	currently	on	the	market	
for	food	supplements	come	from	the	algae	Haematococcus pluvialis	and	krill.	However	other	natural	sources	can	
be	found	and	may	be	of	 interest.Cellular	uptake	studies	were	performed	on	Caco-2/TC7	colonic	cells.	The	cells	
were	cultured	on	a	semi-permeable	membrane	to	create	a	polarized	and	functional	epithelium,	representative	of	
the	intestinal	barrier.	Four	sources	of	astaxanthin	were	selected	and	compared;	synthetic,	natural	extracts	from	
bacteria,	algae	or	yeast.	Astaxanthin	was	incorporated	at	a	concentration	of	5µM	into	mixed	micelles	and	applied	
to	cultured	cellsand	concentration	of	astaxanthin	measured	by	HPLC	in	both	apical	and	basolateral	compartments.	
Small	variations	in	bioavailability	were	observed	at	3	hours.	After	6	hours,	only	the	algae	source	of	astaxanthin	
was	 still	 present	 in	 the	 apical	 compartment	 as	 the	 esterified	 form.	 Structure-activity	 relationships	 are	 further	
discussed.	Animal	 experiments	usingyeast	 and	algae	 sources	 in	different	 types	of	matrices	 confirm	 the	 role	of	
source	and	formulation	in	the	bioavailability	potential	of	astaxanthin.
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 INTRODUCTION
Astaxanthin	 belongs	 to	 the	 family	 of	 carot-
enoids	 and	 has	 powerful	 antioxidant	 properties.	
Increasing	interest	has	been	targeted	toward	this	
molecule	and	its	biological	benefits	in	recent	dec-
ades.	Several	studies	compared	the	antioxidant	ac-
tivity	of	astaxanthin	with	other	carotenoids.	One	
study	found	that	astaxanthin	neutralized	twice	as	
efficiently	 singlet	 oxygen	 as	 beta-carotene	 (and	
almost	80	times	more	effective	than	vitamin	E)	in	
chemical	solution	(Mascio	et al.	,	1991).	Lycopene	
by	comparison	was	30%	more	efficient	than	astax-
anthin.	Similar	results	were	observed	by	research-
ers	 working	 on	 in	 vitro	 system	 of	 human	 blood	
cells	 treated	 with	 various	 carotenoids	 and	 then	
exposed	 to	 singlet	 oxygen.	 Again,	 lycopene	 has	
proved	the	most	effective,	followed	by	zeaxanthin	
and	beta-carotene	(Tinkler	et al.,	1994).	Astaxan-
thin	also	neutralizes	free	radicals.	A	study	shows	
that	 it	 is	 50	 times	 more	 effective	 in	 preventing	
peroxidation	 of	 fatty	 acids	 that	 beta-carotene	 or	
zeaxanthin(Terao,	1989).	In	most	aquatic	animals	
in	which	it	can	be	found,	astaxanthin	has	several	
essential	biological	functions,	including	protection	
against	the	oxidation	of	polyunsaturated	essential	
fatty	acids	protect	against	 the	effects	of	UV	 light,	
immune	 response	 modulation,	 pigmentation,	
communication,	 reproductive	 behaviour	 and	 the	
improvement	of	reproduction	(Lorenz	&Cysewski,	
2000).	
Astaxanthin	cannot	be	synthesized	by	most	an-
imals	and	must	be	acquired	from	the	diet.	Although	
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mammals	and	most	fish	are	unable	to	convert	other	
dietary	 carotenoids	 to	 astaxanthin,	 crustaceans	
(such	as	shrimp)	and	some	fish	species	(koi)	have	
a	 limited	ability	 to	 convert	 closely	 related	dietary	
carotenoids	into	astaxanthin,	although	most	astax-
anthin	recovered	comes	from	their	diet.	Mammals	
do	not	have	the	capacity	to	synthesize	astaxanthin	
and	unlike	 beta-carotene	 astaxanthin	 has	 no	pro-
vitamin	A	activity	in	these	animals.	
Astaxanthin	is	naturally	present	in	the	human	
diet	with	seafood	such	as	krill,	shrimp,	lobster,	cod,	
mackerel,	 salmon	or	 other	 coloured	 fish.	 In	wild	
salmon,	 concentrations	 of	 astaxanthin	 can	 reach	
40	mg/kg	while	farmed	salmon	can	only	reach	up	
to	8	mg/kg(Ambatiet al.,	2014).	The	daily	intake	of	
2-4	mg	astaxanthin,	recommended	for	physiologi-
cal	effects,	thus	corresponds	to	the	absorption	of	
100	g	of	wild	salmon	or	500	g	of	farmed	salmon.	
The	main	non-animal	natural	sources	of	astaxan-
thin	 are	 the	 microalgae	 Haematococcus pluvialis 
and	yeast	Phaffia rhodozyma.	Only	algae	astaxan-
thin	is	currently	marketed	as	dietary	supplement	
for	humans;	Phaffia rhodozyma	yeast	extracts	on	
the	other	hand	are	currently	only	used	for	animal	
feed	(fish,	eggs).	The	synthetic	source	is	also	wide-
ly	 used	 in	 animal	 feed,	 while	 production	 by	 the	
bacterium	Paracoccuscarotinifaciens is more anec-
dotal.	These	four	sources	present	specific	geomet-
ric	and	optical	isomers	detailed	in	Tab.	1.The	asta-
xanthin	profile	being	identical	in	fish	flesh	to	that	
present	in	their	diet	(Storebakken	et al.,	1985),	the	
different	forms	used	in	aquaculture	therefore	find	
themselves	indirectly	in	the	human	diet.	
The	 various	 stages	 of	 transportation,	 diges-
tion,	 absorption	 and	 transport	 in	 the	 plasma	 of	
dietary	 carotenoids	were	 examined	 in	mammals	
(Furr&	 Clark,	 1997)but	 also	 because	 these	 com-
pounds	have	been	associated	with	reducing	risks	
of	 certain	 cancers	 and	 chronic	 diseases.	 Full	 un-
derstanding	of	 carotenoid	metabolism	 is	 compli-
cated	by	a	number	of	 factors:	variations	 in	phys-
iochemical	properties	among	carotenoids;	altered	
carotenoid	 utilization	 as	 a	 result	 of	 the	 normal	
vicissitudes	of	lipid	absorption	and	transport;	di-
vergence	 in	 metabolic	 fate	 within	 the	 intestinal	
enterocyte	(especially	carotenoid	cleavage	to	reti-
noids.	 In	plasma,	 the	non-polar	carotenoids	such	
as	beta-carotene,	 alpha-carotene	or	 lycopene	are	
usually	 transported	by	very	 low	density	 lipopro-
teins	 (VLDL)	and	 low	density	 lipoproteins	 (LDL)	
and	 the	 polar	 carotenoids	 such	 as	 zeaxanthin,	
lutein	or	astaxanthin	are	more	likely	to	be	trans-
ported	by	LDL	and	high	density	lipoprotein	(HDL).	
Similarly,	a	limited	number	of	clinical	studies	have	
investigated	 the	 bioavailability	 of	 astaxanthin	
from	 algae	 (Mercke-Odeberget al.,	 2003;	 Okada,	
Ishikura,	&Maoka,	2009)	or	a	synthetic	esterified	
form	(Coral-Hinostrozaet al.,	2004;	Østerlie	et al.,	
2000)pharmacokinetics,	and	distribution	of	astax-
anthin	E/Z	 and	R/S	 isomers	 in	plasma	and	 lipo-
protein	 fractions	were	 studied	 in	 3	middle-aged	
male	volunteers	(37-43	years		but	none	so	far	on	
fermentative	sources	such	as	yeast	or	bacteria.	
To	 our	 knowledge,	 no	 report	 comparing	 the	
different	 sources	 of	 astaxanthin	 has	 been	 pub-
lished.	 This	 study	 therefore	 aims	 to	 compare	 on	a cellular epithelial transport model four sources 
of	astaxanthin	used	in	animal	feed,	some	of	which	are used or intended for human consumption.
MATERIALS AND METHODS 
All	 reagents	were	purchased	 from	Sigma	Al-
drich	 (France),	 except	 for	 the	 different	 astaxan-
thin	 extracts	which	were	 generously	 donated	 by	
Ajinomoto	Foods	Europe,	Algatechnologies	ltd	and	
ACS	Dobfar	spa	 for	 the	yeast,	algae	and	bacterial	
sources,	respectively.	We	followed	an	existing	pro-
tocol	 (Mimoun-Benarroch	 et al.,	 2011)	 to	mimic	
the	 intestinal	 absorption	 of	 lipophilic	 molecules	
solubilized	 in	 the	 form	of	 bile	 salt	micelles.	 This	
formulation,	 based	 on	 the	 composition	 of	 post-
prandial	 duodenal	 contents	 in	 humans	 (Armand	
et al.,	 1996),	 appears	 to	 be	 the	 closest	 to	 physi-
ological	conditions.	In	brief,	cholesterol	(0.1	mM),	
phosphatidyl	choline	(0.5	mM),	lyso-phosphatidyl	
choline	 (1.5	mM),	monoolein	 (0.03	mM),	 sodium	
oleate	 (0.5	 mM)	 and	 astaxanthin	 (5	 µM)	 were	
mixed	 in	 a	 methanol:chloroform	 solution	 (2/1;	
v/v)	and	evaporated	under	a	stream	of	nitrogen.	
Sodium	taurocholate	(5	mM)	was	then	diluted	in	
half	 a	 volume	 of	 culture	medium	 (DMEM)	with-
out	 serum	and	without	phenol	 red	and	added	 to	
the	 dried	 lipid	 residue	 and	 vigorously	mixed	 by	
sonication	at	25	W	for	3	min.	When	the	medium	
is	 translucent,	 the	 second	volume	of	 culture	me-
dium	is	added	and	the	solution	stirred	overnight	
to	allow	 the	micelles	 to	 stabilize.	The	 solution	 is	
filtered	 (0.2	µm)	before	 treatment	 to	 retain	only	
the	uniform	size	of	micelles.
Media	 and	 cell	 culture	 solutions	 were	 pur-
chased	 from	 Life	 Technologies	 (France).	 Caco2/
TC7	 cellswere	 a	 generous	 gift	 from	 Dr	 Monique	
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Rousset	 (Université	 Pierre	 et	 Marie	 Curie-Paris	
6,	 UMR	 S872,	 Les	 Cordeliers,	 Paris).	 They	 were	
cultured	 in	 DMEM	 Glutamax	 medium,	 4.5	 g/L	
glucose,	1	%	antibiotics,	1	%	nonessential	amino	
acids,	 20	 %	 inactivated	 foetal	 calf	 serum,	 in	 an	
incubator	 at	 37	 °C	 and	 10	%	 CO
2
.	 To	mimic	 the	
enterocyte	 transport,	 the	 cells	 were	 seeded	 at	 a	
density	of	0.25	×	106	cells	in	inserts	containing	a	
semi	permeable	PET	membrane	 (23.1	mm	 in	di-
ameter;	 1	 µm	 porosity)	 placed	 in	 6-well	 plates	
(Becton	Dickinson).	The	use	of	inserts	allows	dif-
ferential	 access	 to	 the	 two	 poles	 of	 the	 cell,	 the	
apical	 compartment	 representing	 the	 intestinal	
lumen	 and	 basolateral	 compartment	 represent-
ing	the	internal	circulation.	In	brief,	cells	were	cul-
tured	with	complete	medium	(20%	serum)	for	7	
days	after	 seeding	until	 it	 formed	a	 compact	 cell	
monolayer,	as	validated	by	transepithelial	electri-
cal	resistance	(TEER,	Millipore).	Cells	were	kept	in	
a	serum-free	medium	on	the	apical	side	and	com-
plete	medium	on	the	basolateral	side	for	a	further	
two	weeks	to	induce	differentiation	and	structural	
configuration	 similar	 to	physiological	 conditions.	
The	cells	were	used	after	21	days	of	culture,	that	is	
to	say	when	they	are	contiguous	and	polarized.	On	
D20,	the	culture	media	were	replaced	with	identi-
cal	media	without	phenol	red.	On	D21,	the	apical	
medium	was	replaced	with	500	µl	of	test	medium	
described	in	section	2.1,	while	the	basolateral	me-
dium	was	replaced	with	1.5	mL	complete	medium.	
The	treatment	was	stopped	after	3	or	6	hours	of	
incubation	 by	 collection	 of	 the	 different	 media	
(apical,	basolateral).	Finally	the	cellular	layer	was	
washed	with	PBS	before	being	 scraped	 from	 the	
insert	and	collected	in	500	µl	PBS.	Samples	were	
kept	frozen	(-80	°C)	until	analysis.
The	 extraction	 protocol	 is	 adapted	 from	
Mercke-Odeberg	et al(2003).	Briefly,	6	volumes	of	
hexane	and	6	volumes	of	acetone	were	added,	the	
sample	 vortexed	 for	 1	min	 before	 centrifugation	
for	 5	 min	 at	 2500	 rpm,	 room	 temperature.	 The	
organic	phase	was	transferred	to	a	new	tube	and	
evaporated	 under	 nitrogen	 flux.	 The	 astaxanthin	
pellet	was	recovered	in	200	μL	acetone	for	HPLC	
analysis.	 In	 the	 case	of	 tests	 on	 the	 algae	 source	
of	 astaxanthin,	 the	 extraction	 residue	was	 taken	
up	in	1.5	ml	of	acetone	supplemented	with	1.5	mL	
of	cholesterol	esterase	solution	(Sigma)	in	50	mM	
Tris	HCl	pH	7	(4	U	/	ml)	and	incubated	for	2	h	at	
37	°C,	then	0.5	g	of	sodium	decahydrate	and	1	mL	
of	petrol	ether	were	added	to	the	solution	before	
centrifugation	 3	 min	 at	 3500	 rpm.	 The	 organic	
phase	was	transferred	to	a	new	tube	containing	1	g	
anhydrous	sodium	sulfate.	This	step	was	repeated	
and	the	supernatant	evaporated	under	a	nitrogen	
stream.	 The	 pellet	 was	 recovered	 in	 1.5	 mL	 of	
acetone,	 dissolved	 by	 ultrasound	 for	 30	 sec	 and	
filtered	(0.45	µm)	prior	to	HPLC	analysis.The	HPLC	
system	 (Surveyor	 PDA	 ThermoFisher	 Scientific)	
was	connected	to	a	PDA	detector	selected	to	470	
nm.	YMC	column	30	(25	cm	x	4.6	mm	id;	particles	
5	microns;	pores	100	Å)	was	preceded	by	a	guard	
Tab. 1. Sources	of	astaxanthin	(AX)	and	their	structural	variations
Source AX (ppm)
Optical isomers (%) Geometrical isomers (%) Derivation (%)
3R,3’R 3R,3’S 3S,3’S All-trans Cis Free
Mono-
ester Diester
farmed salmon 2.5-8 25 50 25
wild salmon 5-30 12-17 2-6 78-85
krill 120 9-55 7-21 38-70 75 25 4-5 31-35 61-64
Phaffia rhodozyma
5000-
10000
98 - 2 70-90 10-30 100 - -
Paracoccuscarotinifaciens 20000 - - 100 95 5 100 - -
Haematococcus pluvialis
10000-
40000
4 8 88 70 30 5 85 15
Synthetic 100000 25 50 25 65-75 25-35 100 - -
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column	with	the	same	characteristics.	This	system	
was	kept	at	a	constant	temperature	of	30	°C	during	
elution	(constant	flow	1	ml/min).	After	0.5	min	of	
isocratic	 condition	 using	 4%	 solvent	 A	 (ddH
2
O),	
15%	 of	 solvent	 B	 (MTBE)	 and	 81%	 solvent	 C	
(Methanol),	carotenoids	were	eluted	over	50	min	
with	a	 linear	gradient	of	15	to	90%	of	solvent	B,	
solvent	 A	 remaining	 constant	 throughout	 the	
elution	time.	The	column	was	re-equilibrated	 for	
5	min	between	each	analysis.	Quantification	was	
performed	 using	 a	 standard	 curve	 of	 all-trans	
astaxanthin	 (CaroteNature,	 Swizerland).	 The	
integration	and	analysis	of	astaxanthin	peaks	were	
performed	using	the	ChromQuest	software.	
All	raw	data	were	the	product	of	at	least	two	
independent	 experiments.	 Statistical	 tests	 were	
performed	 using	 SPSS	 v17.0	 for	Windows	 (SPSS	
Inc).	Because	of	 the	 relatively	 small	number	and	
heterogeneity	of	replicates	(n=5	to	13,	depending	
on	the	treatment),	all	statistical	analyses	were	by	
default	non	parametric.	Kruskal-Wallis	tests	were	
performed	to	compare	the	global	sets	of	data	and,	
when	 significant,	 post-hoc	 analyses	 were	 done	
using	Dunn’s	pair	to	pair	comparison.	
RESULTS AND DISCUSSION
Absorption data
The	 absorption	 of	 astaxanthin	 present	 in	
the	 four	sources	was	time-dependent	with	a	me-
dian	value	 for	 the	unabsorbed	 fraction	of	41.2%,	
53.8%,	48.5%,	35.6%	after	3	hours	of	 treatment	
and	 15.6%,	 44.2%,	 2.6%,	 6.7%	 after	 6	 hours	 of	
treatmentfor	the	yeast,	algae,	bacterium	and	syn-
thetic	 sources,	 respectively	 (Fig.	 1).	 Although	 a	
lower	rate	of	absorption	is	observed	at	3	hours	be-
tween	the	esterified	and	free	forms,	the	difference	
is	 only	 significant	 between	 algae	 and	 synthetic	
astaxanthin	(p<0.05).	At	6	hours,	however,	the	dif-
ference	is	statistically	highly	significant	against	all	
three	non-esterified	sources	(p<0.001	for	all	three	
forms).	
As	 a	 control	molecule,	 beta-carotene	 had	 an	
unabsorbed	fraction	of	31.9%	at	3	hours	and	was	
fully	absorbed	after	6	hours.	This	increased	rate	of	
absorption	is	not	significant	at	3	hours	compared	
to	astaxanthin	but	is	significant	at	6	hours	against	
yeast	 (p<0.01)	 and	 algae	 (p<0.001)	 astaxanthin	
but	 not	 the	 two	 other	 sources.Therefore	 even	 if	
the	 transport	mechanism	 is	 via	 passive	 transfer,	the rate of transfer is different. 
Caco2/TC7	cells	were	culture	 for	21	days	on	
transwells	prior	to	treatment.	Astaxanthin	(5µM)	
were	added	on	the	apical	medium	(DMEM	serum	
free)	 and	 the	 apical,	 basal	 (DMED	 10%	 serum)	
and	cell	fractions	were	collected	after	3	or	6	hours.	
Carotenoids	 were	 quantified	 and	 expressed	 as	
percentage	 of	 unabsorbed	 molecule	 (apical).	 All	datapoints are presented on the scatterplot for 
yeast,	 algae,	 bacterium	 and	 synthetic	 sources,	
in	 order.	 Dunn’s	 pair-to-pair	 comparisons	 were	
performed	for	statistical	significance.	*	p<0.05;	***	
p<0.0005
Over	 a	 third	 of	 astaxanthin	 remained	 unab-
sorbed	 (44.2%)	 after	 6	 hours	 for	 the	 algae	
source	(Fig.	1).	As	 the	percentage	of	unabsorbed	
astaxanthin	 is	 not	 greatly	 improved	 between	 3	
and	 6	 hours	 of	 treatment	 (non-significant),	 the	
chromatograms	 confirm	 that	 only	 esterified	
astaxanthin	 remains	 in	 the	 apical	medium	while	
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Fig. 1. Unabsorbed	fractions	of	astaxanthin	isoforms	after	3	and	6	hours	incubation
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only	 free	 form	 is	 present	 in	 the	 cells	 (data	 not	
shown).	 This	 suggests	 a	 role	 for	 hydrolysis	 of	
astaxanthin	esters	 leading	 to	delayed	absorption	of the molecule. 
Transfer	to	the	basolateral	side	was	very	poor	
for	 astaxanthin	 (up	 to	2%,	whatever	 the	 source)	
while	 it	was	 fast	 and	complete	 for	beta-carotene	
(Tab.2).	 This	 difference	 is	 highly	 significant	
(p<0.001)	 against	 all	 sources	 of	 astaxanthin	 at	
both	3	and	6	hours	of	treatment.	From	the	different	
sources	 of	 astaxanthin,	 there	 is	 no	 molecule	
detected	 in	 the	 basolateral	 compartment	 with	
algae	 and	 the	 transfer	 through	 the	 basolateral	
membrane	seems	to	be	time-dependent	for	yeast	
and	synthetic	astaxanthin,	although	very	slow,	but	
not	 for	 the	 bacterial	 astaxanthin.	 The	 question	
remains	 as	 to	 why	 the	 astaxanthin	 accumulates	
in	 the	 cells	 rather	 than	 being	 exported	 to	 the	
basolateral	medium	in	a	similar	manner	 to	beta-
carotene.	This	may	suggest	 the	 implication	of	an	
active	transport	system.	
There	 are	 very	 few	 investigations	 on	 the	
bioavailability	of	astaxanthin	reported.	The	main	
reason	may	be	that	records	of	astaxanthin	used	as	a	
bioactive	molecule	in	human	nutrition	are	no	more	
than	 a	 couple	 of	 decades	 old.	 As	 a	 consequence,	
studies	 of	 this	 carotenoid	 are	 relatively	 sparse.	
In	 addition,	 investigations	 on	 the	 bioavailability	
represent	 only	 a	 very	 small	 part	 of	 the	 available	
publications,	 which	 are	 mostly	 on	 physiological	
benefits.	 It	 may	 be	 as	 well	 due	 to	 the	 highly	
competitive	market	leading	to	preclinical	research	
remaining	 confidential.	 However	 it	 is	 possible	
to	 compare	 our	 results	with	 those	 published	 on	other carotenoids. 
O’Sullivan	et al.	(2004)	showed	that	astaxan-
thin	was	better	accumulated	into	Caco-2	cells	over	
a	 24-hours	 period	 compared	 to	 beta-carotene,	
which	 is	 in	 contradiction	with	 our	 observations.	
However	cells	were	cultured	as	monolayer	rather-
than	on	a	transwell	system	and	the	delivery	matrix	
was	Tween40/80	rather	 than	biliary	micelles.	 In	
addition,	cells	were	treated	with	a	mixture	of	ca-
rotenoids	rather	than	individual	compound,	which	
may	impact	the	absorption	rate	of	individual	mol-
ecules.	A	similar	result	with	higher	cellular	uptake	
and	secretion	to	the	basolateral	side	was	observed	
on	 a	 transwell	 culture	 set-up	 when	 comparing	
astaxanthin	 to	 beta-carotene	 presented	 on	 the	
apical	 side	 in	 Tween40	with	 chylomicron-stimu-
lating	molecules	for	16	hours	(O’Sullivan,	Ryan	&	
O’Brien,	 2007).	 Sy	 et al.	 (2012)	 did	 not	 find	 any	
carotenoid	 into	 the	basolateral	medium	after	a	3	
hours	 incubation	 in	 the	 apical	 side	with	 natural	
or	synthetic	micelles.	This	 is	 consistent	with	our	
observations	for	astaxanthin	(less	than	2%	in	the	
basolateral	fraction)	but	not	beta-carotene.	All	ex-
perimental	 conditions	were	 similar	 between	 the	
two	set-ups.	Our	data	also	showed	a	higher	trans-
fer	rate	to	the	cellular	fraction	at	3	hours	(around	
50%)	compared	to	the	authors	(10%)	but	all	agree	
on	a	similar	uptake	rate	for	the	two	carotenoids	at	
3	hours.	The	higher	uptake	rate	should	not	be	due	
to	adsorbed	carotenoids	as	the	washing	step	was	
performed	in	our	experiments	as	well.
The	rate	of	absorption	measured	was	increa-
sed	for	the	free	form	compared	to	esterified	astax-
anthin	from	algae.	This	is	consistent	with	the	data	
reported	by	Lyons	et al.	(2002),	where	cellular	in-
corporation	from	synthetic	astaxanthin	was	nearly	
twice	higher	than	algae	astaxanthin.	Esterification	
Tab.2. Absorption	of	astaxanthin	and	beta-carotene	by	Caco2/TC7	cells
Source
3h 6h
%	Absorbed	(BL+C) of	which	in	BL %	Absorbed	(BL+C) of	which	in	BL
P.rho 59.22	(6.75) b 1.01	(0.50) b 87.83	(7.54) b 2.20	(1.69) b
P.car 51.94	(13.83) ab 1.19	(2.08) b 94.08	(6.58) c 0.75	(1.58) a
H.plu 45.26	(5.29) a 0.00	(0.00) a 60.20	(9.50) a 0.00	(0.00) a
Synth 64.38	(7.78) b 1.00	(0.95) b 90.78	(4.70) bc 2.54	(1.70) b
B-car 60.32	(15.67) b 55.49	(13.91) c 100.00	(0.00) d 95.87	(6.52) c
Caco2/TC7	cells	were	culture	for	21	days	on	transwells	prior	to	treatment.	Astaxanthin	or	beta-carotene	(5µM)	were	added	on	the	apical	medium	
(DMEM	serum	free)	and	the	apical,	basal	(DMED	10%	serum)	and	cell	fractions	were	collected	after	3	or	6	hours.	Carotenoids	were	quantified	
and	expressed	as	percentage	of	absorbed	molecule	(cell	+	basolateral).	Data	are	expressed	as	mean	and	standard	deviation	and	different	letters	
in	columns	indicate	a	significant	difference	between	the	treatments	(Kruskall-Wallis	followed	by	Dunn’s	pair-to-pair	comparisons).	
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is	 a	 common	 feature	 of	 lipid-soluble	 molecules.	
Carboxyl	 ester	 lipase,	 also	 known	 as	 cholesterol	esterase is produced in the pancreatic juice for an 
activity	at	the	brush	border	(Ikeda	et al.,	2003)	and	
is	the	main	actor	of	hydrolysis	of	carotenoid	esters	
in	 the	 intestinal	 lumen	 before	 absorption	 of	 the	
free	form	by	the	enterocytes.	However,	in	a	similar	
experimental	 setup,	 fucoxanthin	 was	 hydrolysed	
when	exposed	 to	Caco-2	cells	producing	 the	 free	
form	 fucoxanthinol	 similar	 to	 that	 produced	 by	
hydrolysis	with	pancreatic	lipase	(Sugawaraet al.,	
2002).	This	activity	of	endogenous	 lipase	or	car-
boxylesterase	activity	at	 the	apical	membrane	or	
secreted	into	the	apical	medium	close	to	the	brush	
border	 is	consistent	with	previous	reports	 (Ann-aert et al.,	1997;	Spalingeret al.,	1998)”container-
title”:”Biochimica	Et	Biophysica	Acta”,”page”:”119-
127”,”volume”:”1393”,”issue”:”1”,”source”:”Pub
Med”,”abstract”:”Dietary	 triglycerides,	 the	 major	
precursors	of	long	chain	fatty	acids	(FA.	Similarly,	
absorption	of	 zeaxanthin,	 another	 xanthophyll	 is	
facilitated	 by	 prior	 hydrolysis	 of	 its	 esters	 (Chit-
chumroonchokchai&	 Failla,	 2006).	 Therefore	 the	
partial	absorption	of	astaxanthin	and	detection	of	
the	free	form	only	in	the	cellular	fraction	observed	
herein	may	be	due	 to	 the	endogenous	hydrolytic	
activity	 of	 the	 cells.	 Further	 investigations	 need	
to	be	performed	as	well	to	assess	the	esterase	ac-
tivity	 in	 cells	 exposed	 to	 free	 and	 ester	 forms	of	
astaxanthin.	 In	 addition,	 it	may	be	 interesting	 to	
do	a	pre-digestion	with	pancreatic	 juice.	The	up-
take	and	role	of	esterified	astaxanthin	on	mucosal	
absorption	 patterns	 remain	 unclear	 at	 this	 time.	
Sugawara	 et al,	 2009,	 observed	 some	 esterifica-
tion	of	astaxanthin	by	Caco-2	cells	after	24	hours	
treatment.	It	remained	very	partial	with	up	to	2%	
of	the	astaxanthin	present	in	the	basolateral	com-
partment	being	esterified	compared	to	up	to	10%	
for	peridininol	esters.	Although	we	did	not	detect	
any	astaxanthin	esters	in	the	basolateral	medium,	
our	treatment	time	was	much	shorter	at	3	and	6	
hours	and	the	process	may	be	time-dependent(Sy	
et al.,	2012).
Animal	 studies	 (data	 not	 shown)	 have	 been	
performed	 in	 order	 to	 better	 understand	 the	impact of the source and the food matrix in 
absorption	 parameters.	 A	 study	 on	 hamsters	
showed	 that	 powder	matrix	 greatly	 reduced	 the	
plasma	 recovery	 of	 astaxanthin	 from	 the	 yeast	
Phaffia rhodozyma	and	delays	the	peak	of	plasma	
concentration	by	up	to	4	hours.	This	is	in	agreement	
with	 the	 clinical	 study	 from	 Mercke-Odeberg	 et 
al	 (2003)	 showing	 an	 increased	 bioavailability	
of	 astaxanthin	 from	 the	 algae	 Haematococcus 
pluvialis	 in	 lipid	 compared	 to	 powder	 matrix.	
Another	 study	 in	 rats	 compared	 the	 two	 main	
sources	 (algae	 and	 yeast)	 prepared	 in	 the	 same	
lipid	 carrier	 (safflower	 oil).	 Data	 showed	 that	
this	 specific	 carrier	 was	 not	 suitable	 to	 dissolve	
the	 free	 form	 (yeast)	 into	 a	 solution	 but	 rather	
into	 a	 fine	 suspension	 of	 astaxanthin	 crystals.	
Hence,	the	bioavailability	was	much	lower	for	the	
yeast	compared	to	algae	due	to	the	exchange	area	
that	 was	much	 lower	 (Ajinomoto	 Foods	 Europe,	
personal	data).
These	 studies	 were	 thus	 contradictory	 with	the in vitro	data	regarding	the	rate	of	absorption	
between	 yeast	 and	 algae	 astaxanthin.	 However	
two	reasons	can	be	suggested	for	this	observation.	
The	first	is	in	the	formulation	for	the	in	vivo	stud-
ies,	leading	to	lower	solubility	of	the	free	form	thus	
lower	 available	 concentration	 of	 the	 molecules.	
The	second	may	be	related	to	hydrolysis	of	astax-
anthin	esters	on	the	 intestinal	area,	possibly	due	
to	stimulation	of	the	enzyme	through	the	presence	
of	the	ester,	which	was	not	observed	in vitro.
Mechanisms of action
The	 expression	 of	 several	 lipid	 carriers	
was	 measured	 by	 RT-qPCR	 after	 3	 and	 6	 hours	
of	 treatment	 (data	 not	 shown).	 The	 maximum	
expression	 was	 observed	 at	 6	 hours,	 when	 the	
absorption	 was	 mostly	 complete.	 The	 activation	
therefore	 is	not	necessarily	directly	related	to	an	
active	transport	of	the	molecules.	Incubation	with	
carotenoid-free	 micelles,	 a	 wide	 range	 of	 genes	
were	modulated,	indicating	that	most	carriers	were	
modulated	 primarily	 by	 bile	 acids,	 in	 agreement	
with	the	physiological	mechanisms	of	absorption	
of	 dietary	 lipids.	 When	 comparing	 astaxanthin	
treatments	against	micelles,	very	few	modulations	
were	 significant.	 Astaxanthin	 from	 the	 yeast	
Phaffia rhodozyma stimulated the expression 
of	 a	 range	 of	 genes	 at	 6	 hours,	 including	 Fabp2	
(p<0.05),	 Scarb1	 (p<0.05)	 and	 Scp2	 (p<0.01).	
Astaxanthin	 from	 algae	 Haematococcus pluvialis 
stimulated	expression	of	Scarb1	(p<0.05)	and	Scp2	
(p<0.05)	at	6	hours.	Synthetic	astaxanthin,	finally,	
stimulated	 the	 expression	 of	 Scp2	 (p<0.05)	 at	 6	
hours,	 while	 bacterial	 astaxanthin	 did	 not	 seem	
to	significantly	affect	any	gene	expression.	All	this	
may	 suggest	 a	 structure-dependent	 activation	
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of	 the	 lipid	 carriers	 involved	 in	 the	 uptake	 or	
at	 least	 stimulated	 by	 astaxanthin	 isomers.	 In	
the	case	of	Scp2,	a	possibility	may	be	 the	role	of	
the	 geometrical	 isomer	 cis-astaxanthin	 which	 is	
virtually	 absent	 from	 the	 bacterial	 extracts	 and	
present	in	up	to	30%	in	the	other	forms	(Tab.	1).
During	et al.	 (2005)	 in	a	cell	study	using	the	
Caco-2	cell	line	showed	that	the	bioavailability	of	
carotenoids	was	partially	 inhibited	by	 the	use	of	
an	antagonist	of	cholesterol	transport.	Apolar	ca-
rotenoids	seemed	more	sensitive	to	this	inhibition	
compared	to	polar	carotenoids	such	as	zeaxanthin	
or	 lutein.	 An	 inhibitor	 of	 the	 SR-B1	 transporter	
also	 had	 a	 partial	 effect	 on	 carotenoids	 uptake,	
suggesting	 a	 role	 in	 active	 transport	 of	 beta-car-
otene.	The	results	of	Reboul	et al.(2005),	suggest-
ing	 that	 lutein	 is	 at	 least	 partially	 carried	 by	 an	
active	 mechanism	 involving	 the	 SR-B1	 receptor.	
Further	work	reviewed	in	2013	point	to	the	role	of	
SR-B1	carrier	protein	for	a	range	of	carotenes	and	
xanthophylls(Reboul,	 2013).	 The	 corresponding	
gene,	 Scarb1	 was	 modulated	 by	 both	 beta-caro-
tene	and	some	sources	of	astaxanthin	in	our	study.
The	inhibition	of	the	expression	of	AbcA1	is	how-
ever	inconsistent	with	the	putative	role	of	the	car-rier protein in the excretion of carotenoids on the 
basolateral	membrane	of	the	enterocyte	(Reboul,	
2013),	nor	 is	 it	 consistent	with	 the	high	 transfer	
rate	of	beta-carotene	to	the	basolateral	medium	as	
observed	herein.	Our	tests	have	not	to	date	includ-
ed	the	use	of	inhibitors	of	the	lipid	carriers	high-
lighted	in	our	results	or	suggested	in	publications.	
Additional	tests	will	be	needed	to	refine	these	ob-
servations	and	to	better	understand	variations	be-
tween	the	different	sources	of	astaxanthin.	
The	RIVAGE	study	(Lairon	et al.,	2009;	Vincent	
et al.,	2002)showed	a	relationship	between	a	poly-
morphism	of	the	gene	Scarb1	(SR-B1	transporter)	
and	cardiovascular	markers	like	blood	sugar,	insu-
lin	 and	 cholesterol	 levels,	while	 Fabp2	 polymor-
phism	had	lower	physiological	repercussions	but	
mainly	on	triglycerides.	Variations	and	stimulation	
of	lipid	metabolism	genes	could	have	a	functional	
impact	beyond	the	active	transport	of	carotenoid.	
As	the	genetic	expression	was	at	the	highest	once	
absorption	was	completed,	 the	 transporters	may	
be	 involved	 in	 facilitated	 uptake	 of	 other	 lipids	
rather	 than	astaxanthin	 itself.	With	 this	 in	mind,	
most	 forms	 of	 astaxanthin	 seem	 to	 particularly	
target	the	intestinal	sterol	carrier	protein	(SCP2)	
and	modulate	 bile	 acid	 excretion	 into	 the	 lumen	
and formation of lipid carriers such as micelles for 
general	 lipid	uptake	 as	well	 as	 intracellular	 cho-
lesterol	transport	(Shen,	Howles,	&Tso,	2001).The	
wider	effect	of	the	yeast	astaxanthin	may	suggest	a	
further	role	in	stimulating	circulating	HDL-choles-
terol	(SR-B1)	or	the	intestinal	recognition	protein	
and	intracellular	utilization	of	long	chain	fatty	ac-
ids	and	their	esters	(FABP2).	
CONCLUSION 
We	have	 observed	 through	 this	 series	 of	 ex-
periments	variation	in	the	bioavailability	and	gene	
expression	of	 lipid	 carriers	 after	 treatment	 for	3	
to	6	hours	of	Caco-2/TC7	cells	with	astaxanthin	in	
mixed	micelles.	Our	main	conclusion	relates	to	the	
delay	in	uptake	due	to	the	esterification	of	astax-
anthin,	 the	algae	source	being	partially	absorbed	
when	the	free	form	in	the	yeast	or	other	extracts	is	
nearly	completely	absorbed	after	6	hours	of	treat-
ment.	We	found	very	few	differences	between	geo-
metric	and	optical	isomers	of	astaxanthin,	but	fur-
ther	structural	study	would	be	needed	to	confirm	
those	 observations.	 .	 Further	 investigations	 are	
required	as	the	esterified	form	from	algae	is	cur-
rently	the	only	non-dietary	source	of	astaxanthin	
present	for	human	nutrition	and	while	their	physi-
ological	effects	seem	to	be	more	and	more	dissect-
ed,	the	first	contact	with	the	host	at	the	intestinal	
mucosal	barrier	remains	a	black	box.
Our	 second	 conclusion	 is	 based	 on	 the	 ex-
pression	 of	 genes	 related	 to	 lipid	 or	 cholesterol	
transport,	some	of	which	are	also	known	to	be	in-
volved	in	the	transport	of	carotenoids,	but	the	tim-
ing	seems	off	between	the	observed	uptake	of	the	
molecule	and	genetic	expression.	The	implications	
are	perhaps	more	complex	and	the	RIVAGE	study	
suggests	 possible	 physiological	 consequences	 of	
modulating	these	carriers.	
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